A Computer Assisted Method to Obtain the Prothrombin Activation Velocity in Whole Plasma Independent of Thrombin Decay Processes

 

PDF Download Buy Article Permissions and Reprints

Summary

A method is described that, on the basis of the time course of amidolytic activity after the triggering of thrombin generation in normal plasma, allows the calculation of the velocity of prothrombin conversion independent of thrombin inactivating processes.

It is shown how the reaction constants for the α₂M-dependent and the α₂M-independent thrombin inactivation processes can be obtained in a sample of whole plasma.

The method is verified by demonstrating that the experimentally observed time courses of residual prothrombin and of α₂M-thrombin complex coincide with those calculated from the time course of amidolytic activity, and by showing that the course of prothrombin conversion in plasma without α₂-macroglobulin or AT III is adequately described if the α₂M or AT Ill-dependent breakdown constants are taken zero in the calculations.

It appears that the inactivation of thrombin, endogenously generated in whole plasma, is about half as fast as that of exogenous thrombin added to the plasma.

A computer program is presented that carries out the relevant calculations.

• References

• 1 Wagner RH, Graham JB, Penick GD, Brinkhous KM. Estimation of prothrombin by the two stage method. In: Blood coagulation, Hemorrhage and Thrombosis Tocantins ML, Kazal LA. (eds) Academic Press; New York - London: 1965
• 2 Biggs R, Macfarlane RG. Human blood coagulation and its disorders. Blackwell Scientific Publications; Oxford: 1967
  Google Scholar
• 3 Hemker HC, Hemker PW, vd Torren K, Devilee PP, Hermens WTh, Loeliger EA. The evaluation of the two-stage prothrombin assay. Thromb Diathes Haemorrh 1971; 25: 545-554
  PubMedGoogle Scholar
• 4 Pekelharing CA. Over de betrekking van het fibrineferment van het bloedserum tot de nucleoproteide van het bloedplasma. Versl Kon Acad Wetensch Amsterdam 1895; 3: 272-297
  PubMedGoogle Scholar
• 5 Travis J, Salvesen GS. Human plasma proteinase inhibitors. Ann Rev Biochem 1983; 52: 655-709
  CrossrefPubMedGoogle Scholar
• 6 Rosenberg RD, Harpel PC. α₂-Macroglobulin and antithrombinheparin cofactor: modulators of hemostatic and inflammatory reactions. Prog Hemost Thromb 1976; 3: 145-198
  PubMedGoogle Scholar
• 7 Barret AJ, Starkey PM. The interaction of α₂macroglobulin with proteinase. Biochem J 1973; 133: 709-715
  CrossrefPubMedGoogle Scholar
• 8 Harpel PC. Studies on human plasma α₂-macroglobulin enzyme interactions. Evidence for proteolytic modification of the subunit chain structure. J Exp Med 1973; 138: 508-521
  CrossrefPubMedGoogle Scholar
• 9 Rinderknecht H, Feling RM, Geokas MC. Effect of α₂-macroglobulin in some kinetic parameters of trypsin. Biochim Biophys Acta 1975; 377: 150-165
  PubMedGoogle Scholar
• 10 Fischer AM, Tapon-Bretaudière J, Bros A, Josso F. Respective roles of antithrombin III and α₂-macroglobulin in thrombin inactivation. Thromb Haemostas 1981; 45: 51-54
  PubMedGoogle Scholar
• 11 Josso F, Prou-Wartelle O. Exploration de l’hémostase. In: Techniques en hématologie Alagille D. et al. (eds) pp 101-208 Flamarion; Paris: 1972
• 12 van Dam-Mieras MC E, Muller AD, van Dieijen G, Hemker HC. Methods of enzymatic analysis Enzymes 3: Peptidases, proteinase and their inhibitors. Verlag Chemie, Weinheim 1984; 5: 352-394
  PubMedGoogle Scholar
• 13 Ødegard OR, Lie M. On the use of chromogenic substrates for the study of coagulation inhibitors. Haemostasis 1978; 7: 121-126
  PubMedGoogle Scholar
• 14 Owren PA, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 1951; 3: 201-218
  CrossrefPubMedGoogle Scholar
• 15 Hendrix H, Lindhout T, Mertens K, Engels W, Hemker HC. Activation of human prothrombin by stoichiometric levels of staphy-locoagulase. J Biol Chem 1983; 258: 3637-3644
  PubMedGoogle Scholar
• 16 Steinbuch M, Audran R. Isolement de l’immunoglobuline IgG du plasma humain à l’aide de l’acide caprylique. Rev Franç Etud clin biol 1969; 14: 1054-1058
  PubMedGoogle Scholar
• 17 Lindhout T, Baruch D, Schoen P, Franssen J, Hemker HC. Thrombin generation and inactivation of antïthrombin III and heparin. (Submitted for publication)
  PubMedGoogle Scholar
• 18 Kawabata S, Morita T, Iwanaga S, Igarashi H. Staphylocoagulase-binding region in human prothrombin. J Biochem 1985; 97: 329-331
  PubMedGoogle Scholar
• 19 Rosenberg RD, Damus PS. The purification and mechanism action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 6490-6505
  PubMedGoogle Scholar
• 20 Downing MR, Bloom JW B, Mann KG. Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry 1978; 17: 2649-2653
  CrossrefPubMedGoogle Scholar
• 21 Rosing J, Zwaal RF A, Tans G. Formation of meizothrombin as an intermediate in Factor Xa-catalyzed prothrombin activation. J Biol Chem 1986 (In press)
  PubMedGoogle Scholar
• 22 Esmon CT, Jackson CM. The conversion of prothrombin to thrombin. IV. The function of the fragment 2 region during activation in the presence of factor V. J Biol Chem 1974; 249: 7791-7797
  PubMedGoogle Scholar
• 23 Jesty J. The kinetics of inhibition of thrombin by antithrombin in the presence of components of the hemostatic systems. Blood 1985; 66: 1189-1195
  PubMedGoogle Scholar
• 24 Hemker HC, Willems G, Béguin S. Thrombinoscope, a personal computer program for the analysis of thrombin generation curves. Computers in Biol and Med. (Submitted)
  PubMedGoogle Scholar